Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | pyruvate kinase, putative | 0.0033 | 0.0229 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.2278 | 0.328 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0244 | 0.7231 | 0.7934 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0229 | 0.0229 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0205 | 0.5918 | 0.6446 |
Loa Loa (eye worm) | RNA binding protein | 0.0126 | 0.3306 | 0.3486 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.3306 | 0.4927 |
Echinococcus granulosus | GPCR family 2 | 0.0095 | 0.2278 | 0.2096 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0126 | 0.3306 | 0.3486 |
Echinococcus granulosus | neuropeptide receptor | 0.0221 | 0.6475 | 0.6392 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0095 | 0.2278 | 0.2321 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0723 | 0.0791 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.3306 | 0.4927 |
Onchocerca volvulus | 0.0048 | 0.073 | 1 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0723 | 0.0723 |
Brugia malayi | RNA binding protein | 0.0126 | 0.3306 | 0.3486 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0221 | 0.6475 | 0.6475 |
Loa Loa (eye worm) | TAR-binding protein | 0.0126 | 0.3306 | 0.3486 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0299 | 0.9055 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.3306 | 0.4927 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0229 | 0.0229 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0048 | 0.0723 | 0.056 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0723 | 0.0791 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0033 | 0.0229 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.2278 | 0.328 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.2278 | 0.328 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5918 | 0.9109 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.2278 | 0.328 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0095 | 0.2278 | 0.2278 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0033 | 0.0229 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.5918 | 0.6446 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0033 | 0.0229 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.0723 | 0.0791 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0033 | 0.0229 | 0.5 |
Plasmodium falciparum | pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.0723 | 0.0506 |
Brugia malayi | MH2 domain containing protein | 0.0244 | 0.7231 | 0.7934 |
Chlamydia trachomatis | pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0328 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0126 | 0.3306 | 0.3486 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.2278 | 0.2321 |
Giardia lamblia | Pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.3306 | 0.4927 |
Mycobacterium ulcerans | pyruvate kinase | 0.0033 | 0.0229 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0095 | 0.2278 | 0.2321 |
Loa Loa (eye worm) | hypothetical protein | 0.0299 | 0.9055 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0126 | 0.3306 | 0.3306 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.073 | 0.0567 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.0723 | 0.0506 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0048 | 0.073 | 0.0802 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0095 | 0.2278 | 0.2321 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.0723 | 0.0723 |
Echinococcus multilocularis | neuropeptide receptor | 0.0221 | 0.6475 | 0.6475 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0299 | 0.9055 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0126 | 0.3306 | 0.4927 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0095 | 0.2278 | 0.2096 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0229 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0095 | 0.2278 | 0.2278 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0299 | 0.9055 | 1 |
Plasmodium vivax | pyruvate kinase, putative | 0.0033 | 0.0229 | 0.5 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0033 | 0.0229 | 0.5 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0229 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0048 | 0.0723 | 0.056 |
Brugia malayi | TAR-binding protein | 0.0126 | 0.3306 | 0.3486 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0244 | 0.7231 | 0.7934 |
Echinococcus granulosus | tar DNA binding protein | 0.0126 | 0.3306 | 0.3149 |
Schistosoma mansoni | neuropeptide receptor | 0.0221 | 0.6475 | 1 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0033 | 0.0229 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0095 | 0.2278 | 0.2278 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0095 | 0.2278 | 0.2096 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.